China Tech. Shanghai Experts Lead Research on Congenital Deafness Genetic Therapy Guideline
City News Service
4th November 2025
China Tech. Shanghai Experts Lead Research on Congenital Deafness Genetic Therapy Guideline
by Cai Wenjun
China Tech is a column dedicated to the innovations reshaping China – and, inevitably, the world. From cutting-edge AI labs and next-gen robotics to homegrown apps that redefine daily life, we explore the breakthroughs that emerge from the country's relentless drive for technological dominance. Some are game-changers, others cautionary tales, but all offer a glimpse into the future as it's being built, at breakneck speed, in China.
The world's first international expert consensus on gene therapy for hereditary hearing loss has been published. Specialists from the Eye, Ear, Nose, and Throat Hospital of Fudan University in Shanghai led this research.
A total of 46 leading specialists from various countries contributed to the research.
According to the World Health Organization, approximately 430 million people worldwide experience hearing disabilities, including 34 million children. For individuals with congenital deafness, about 60 percent of cases are linked to genetic defects, which significantly affect language, cognition, and intelligence development. More than 200 genes associated with deafness have been identified, yet no effective medications are available at this time.
Comments